(Q46486256)

English

Effects of glutamine on proinflammatory gene expression and activation of nuclear factor kappa B and signal transducers and activators of transcription in TNBS-induced colitis

scientific article published in November 2008

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

22 December 2017

http://europepmc.org/abstract/MED/18623154

Effects of glutamine on proinflammatory gene expression and activation of nuclear factor kappa B and signal transducers and activators of transcription in TNBS-induced colitis (English)

1 reference

Europe PubMed Central

22 December 2017

http://europepmc.org/abstract/MED/18623154

José L. Mauriz

3

1 reference

Europe PubMed Central

22 December 2017

http://europepmc.org/abstract/MED/18623154

Javier González-Gallego

6

1 reference

Europe PubMed Central

22 December 2017

http://europepmc.org/abstract/MED/18623154

María J. Tuñón

7

1 reference

Europe PubMed Central

22 December 2017

http://europepmc.org/abstract/MED/18623154

author name string

Nelson A Kretzmann

1

1 reference

Europe PubMed Central

22 December 2017

http://europepmc.org/abstract/MED/18623154

Henrique Fillmann

2

1 reference

Europe PubMed Central

22 December 2017

http://europepmc.org/abstract/MED/18623154

Claudio Augusto Marroni

4

1 reference

Europe PubMed Central

22 December 2017

http://europepmc.org/abstract/MED/18623154

Norma Marroni

5

1 reference

Europe PubMed Central

22 December 2017

http://europepmc.org/abstract/MED/18623154

publication date

1 November 2008

1 reference

Europe PubMed Central

22 December 2017

http://europepmc.org/abstract/MED/18623154

Inflammatory Bowel Diseases

1 reference

Europe PubMed Central

22 December 2017

http://europepmc.org/abstract/MED/18623154

14

1 reference

Europe PubMed Central

22 December 2017

http://europepmc.org/abstract/MED/18623154

11

1 reference

Europe PubMed Central

22 December 2017

http://europepmc.org/abstract/MED/18623154

1504-1513

1 reference

Europe PubMed Central

22 December 2017

http://europepmc.org/abstract/MED/18623154

Glutamine inhibits over-expression of pro-inflammatory genes and down-regulates the nuclear factor kappaB pathway in an experimental model of colitis in the rat

1 reference

https://api.crossref.org/works/10.1002%2FIBD.20543

21 January 2018

Superoxide dismutase ameliorates TNBS-induced colitis by reducing oxidative stress, adhesion molecule expression, and leukocyte recruitment into the inflamed intestine.

1 reference

https://api.crossref.org/works/10.1002%2FIBD.20543

21 January 2018

Quercetin prevents oxidative stress and NF-kappaB activation in gastric mucosa of portal hypertensive rats

1 reference

https://api.crossref.org/works/10.1002%2FIBD.20543

21 January 2018

Dietary glycine inhibits activation of nuclear factor kappa B and prevents liver injury in hemorrhagic shock in the rat.

1 reference

https://api.crossref.org/works/10.1002%2FIBD.20543

21 January 2018

The anti-inflammatory flavones quercetin and kaempferol cause inhibition of inducible nitric oxide synthase, cyclooxygenase-2 and reactive C-protein, and down-regulation of the nuclear factor kappaB pathway in Chang Liver cells

1 reference

https://api.crossref.org/works/10.1002%2FIBD.20543

21 January 2018

Role of oxidative stress in the increased activation of signal transducers and activators of transcription-3 in the fatty livers of obese Zucker rats

1 reference

https://api.crossref.org/works/10.1002%2FIBD.20543

21 January 2018

STATs: signal transducers and activators of transcription

1 reference

https://api.crossref.org/works/10.1002%2FIBD.20543

21 January 2018

Growth hormone inhibits signal transducer and activator of transcription 3 activation and reduces disease activity in murine colitis.

1 reference

https://api.crossref.org/works/10.1002%2FIBD.20543

21 January 2018

Il-6 signaling in inflammatory bowel disease: pathophysiological role and clinical relevance

1 reference

https://api.crossref.org/works/10.1002%2FIBD.20543

21 January 2018

Melatonin reduces inflammatory injury through inhibiting NF-kappaB activation in rats with colitis

1 reference

https://api.crossref.org/works/10.1002%2FIBD.20543

21 January 2018

Regulative potential of glutamine--relation to glutathione metabolism.

1 reference

https://api.crossref.org/works/10.1002%2FIBD.20543

21 January 2018

The use of glutamine in the treatment of gastrointestinal disorders in man.

1 reference

https://api.crossref.org/works/10.1002%2FIBD.20543

21 January 2018

Glutamine-enriched total parenteral nutrition in patients with inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1002%2FIBD.20543

21 January 2018

Topical glutamine therapy in experimental inflammatory bowel disease.

1 reference

https://api.crossref.org/works/10.1002%2FIBD.20543

21 January 2018

Prophylactic administration of topical glutamine enhances the capability of the rat colon to resist inflammatory damage

1 reference

https://api.crossref.org/works/10.1002%2FIBD.20543

21 January 2018

The immunology of mucosal models of inflammation

1 reference

https://api.crossref.org/works/10.1002%2FIBD.20543

21 January 2018

Critical appraisal of the current practice in murine TNBS-induced colitis

1 reference

https://api.crossref.org/works/10.1002%2FIBD.20543

21 January 2018

Reduction of experimental colitis in the rat by inhibitors of glycogen synthase kinase-3beta.

1 reference

https://api.crossref.org/works/10.1002%2FIBD.20543

21 January 2018

Oxidative stress induced by Cremophor EL is not accompanied by changes in NF-kappaB activation or iNOS expression

1 reference

https://api.crossref.org/works/10.1002%2FIBD.20543

21 January 2018

Effects of FK506 and rapamycin on generation of reactive oxygen species, nitric oxide production and nuclear factor kappa B activation in rat hepatocytes

1 reference

https://api.crossref.org/works/10.1002%2FIBD.20543

21 January 2018

Immunosuppressive activity of a new pteridine derivative (4AZA1378) alleviates severity of TNBS-induced colitis in mice

1 reference

https://api.crossref.org/works/10.1002%2FIBD.20543

21 January 2018

Animal models of inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1002%2FIBD.20543

21 January 2018

Hepatocyte growth factor facilitates the repair of large colonic ulcers in 2,4,6-trinitrobenzene sulfonic acid-induced colitis in rats

1 reference

https://api.crossref.org/works/10.1002%2FIBD.20543

21 January 2018

Effects of steroid treatment on activation of nuclear factor kappaB in patients with inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1002%2FIBD.20543

21 January 2018

A molecular mechanism for the anti-inflammatory effect of taurine-conjugated 5-aminosalicylic acid in inflamed colon

1 reference

https://api.crossref.org/works/10.1002%2FIBD.20543

21 January 2018

In vivo quercitrin anti-inflammatory effect involves release of quercetin, which inhibits inflammation through down-regulation of the NF-kappaB pathway

1 reference

https://api.crossref.org/works/10.1002%2FIBD.20543

21 January 2018

Protection from experimental colitis by theaflavin-3,3'-digallate correlates with inhibition of IKK and NF-kappaB activation

1 reference

https://api.crossref.org/works/10.1002%2FIBD.20543

21 January 2018

Beneficial effects of GW274150 treatment on the development of experimental colitis induced by dinitrobenzene sulfonic acid

1 reference

https://api.crossref.org/works/10.1002%2FIBD.20543

21 January 2018

Chemopreventive effect of plant originated glycoprotein on colitis-mediated colorectal cancer in A/J mice

1 reference

https://api.crossref.org/works/10.1002%2FIBD.20543

21 January 2018

An inhibitor of IkappaB kinase, BMS-345541, blocks endothelial cell adhesion molecule expression and reduces the severity of dextran sulfate sodium-induced colitis in mice

1 reference

https://api.crossref.org/works/10.1002%2FIBD.20543

21 January 2018

CIS3/SOCS3/SSI3 plays a negative regulatory role in STAT3 activation and intestinal inflammation

1 reference

https://api.crossref.org/works/10.1002%2FIBD.20543

21 January 2018

Activation of signal transducer and activator of transcription (STAT) 1 in human chronic inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1002%2FIBD.20543

21 January 2018

Equol inhibits nitric oxide production and inducible nitric oxide synthase gene expression through down-regulating the activation of Akt.

1 reference

https://api.crossref.org/works/10.1002%2FIBD.20543

21 January 2018

Cordycepin inhibits lipopolysaccharide-induced inflammation by the suppression of NF-kappaB through Akt and p38 inhibition in RAW 264.7 macrophage cells

1 reference

https://api.crossref.org/works/10.1002%2FIBD.20543

21 January 2018

The cyclo-oxygenase-2 inhibitor, rofecoxib, attenuates mucosal damage due to colitis induced by trinitrobenzene sulphonic acid in rats

1 reference

https://api.crossref.org/works/10.1002%2FIBD.20543

21 January 2018

The immunological and genetic basis of inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1002%2FIBD.20543

21 January 2018

Paeonol attenuates TNBS-induced colitis by inhibiting NF-κB and STAT1 transactivation

1 reference

https://api.crossref.org/works/10.1002%2FIBD.20543

21 January 2018

Identifiers

10.1002/IBD.20543

1 reference

Europe PubMed Central

22 December 2017

http://europepmc.org/abstract/MED/18623154

1 reference

Europe PubMed Central

22 December 2017

http://europepmc.org/abstract/MED/18623154

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46486256&oldid=2113467676"